EFFECTS OF N-DI-PROPYLACETATE ON AGGRESSIVE BEHAVIOR AND BRAIN GABA LEVEL IN ISOLATED MICESIMLER S; PUGLISI ALLEGRA S; MANDEL P et al.1983; PHARMACOLOGY, BIOCHEMISTRY AND BEHAVIOR; ISSN 0091-3057; USA; DA. 1983; VOL. 18; NO 5; PP. 717-720; BIBL. 22 REF.Article

ASYMPTOMATIC HYPERAMMONEMIA IN PATIENTS RECEVING VALPROIC ACIDMURPHY JV; MARQUARDT K.1982; ARCHIVES OF NEUROLOGY (CHICAGO); ISSN 0003-9942; USA; DA. 1982; VOL. 39; NO 9; PP. 591-592; BIBL. 12 REF.Article

VALPROIC ACID AND SECONDARY HYPERAMMONEMIASUMANT RAWAT; BORKOWSKI WJ JR; SWICK HM et al.1981; NEUROLOGY; ISSN 0028-3878; USA; DA. 1981; VOL. 31; NO 9; PP. 1173-1174; BIBL. 18 REF.Article

DETERMINATION RAPIDE DE L'ACIDE VALPROIQUE PAR SIBYLATION INSTANTANEELACROIX C; LEVERT P; GOULLE JP et al.1982; ANNALES DE BIOLOGIE CLINIQUE; ISSN 0003-3898; FRA; DA. 1982; VOL. 40; NO 6; PP. 681-683; ABS. ENG; BIBL. 12 REF.Article

INSUFFISANCE HEPATIQUE AIGUE MORTELLE AU COURS D'UN TRAITEMENT PAR LE VALPROATE DE SODIUMLE BIHAN G; COQUEREL A; HOUSSIN D et al.1982; GASTROENTEROL. CLIN. BIOL.; ISSN 0399-8320; FRA; DA. 1982; VOL. 6; NO 5; PP. 477-481; ABS. ENG; BIBL. 28 REF.Article

THE RELATIONSHIP BETWEEN PLASMA CONCENTRATION OF VALPROIC ACID AND ITS ANTICONVULSANT AND BEHAVIOURAL EFFECTS IN THE RATTULLOCH IF; WALTER DS; HOWE GM et al.1982; NEUROPHARMACOLOGY; ISSN 0028-3908; GBR; DA. 1982; VOL. 21; NO 6; PP. 555-562; BIBL. 31 REF.Article

VALPROATE TREMORSPHARM BJK; WILDER BJ; HAMMOND EJ et al.1982; NEUROLOGY; ISSN 0028-3878; USA; DA. 1982; VOL. 32; NO 4; PP. 428-432; BIBL. 20 REF.Article

TREATMENT OF EPILEPSY IN WOMEN OF CHILD-BEARING AGE: PATIENTS' OPINION OF TERATOGENIC POTENTIAL OF VALPROATEPHILBERT A; PEDERSEN B.1983; ACTA NEUROLOGICA SCANDINAVICA. SUPPLEMENTUM; ISSN 0065-1427; DNK; DA. 1983; VOL. 67; NO 94; PP. 35-38; BIBL. 11 REF.Article

MECHANISM OF ANTICONVULSANT ACTION OF VALPROATECHAPMAN A; KEANE PE; MELDRUM BS et al.1982; PROGRESS IN NEUROBIOLOGY; ISSN 0301-0082; GBR; DA. 1982; VOL. 19; NO 4; PP. 315-359; BIBL. 10 P.Article

ORTHOSTATIC HYPOTENSION IN FAMILIAL AMYLOID POLYNEUROPATHY: TREATMENT WITH DL-THREO-3,4-DI-HYDROXYPHENYLSERINESUZUKI T; HIGA S; SAKODA S et al.1981; NEUROLOGY; ISSN 0028-3878; USA; DA. 1981; VOL. 31; NO 10; PP. 1323-1326; BIBL. 17 REF.Article

L'HYPERAMMONIEMIE: UNE CONSEQUENCE INEVITABLE DES TRAITEMENTS PAR LE VALPROATE DE SODIUMWARTER JM; MARESCAUX C; RUMBACH L et al.1981; J. MED. STRASB.; ISSN 0021-7905; FRA; DA. 1981; VOL. 12; NO 6; PP. 421-422; BIBL. 8 REF.Article

ETATS STUPOREUX AU COURS DES TRAITEMENTS PAR LE VALPROATE DE SODIUM: HYPOTHESES PATHOGENIQUESMARESCAUX C; RUMBACH L; WARTER JM et al.1981; REV. NEUROL.; ISSN 0035-3787; FRA; DA. 1981; VOL. 137; NO 4; PP. 241-254; ABS. ENG; BIBL. 21 REF.Article

VALPROIC ACID (DEPAKENEREG.-ABBOTT)BECKNER RR.1979; DRUG INTELLIG. CLIN. PHARM.; USA; DA. 1979; VOL. 13; NO 1; PP. 18-21; BIBL. 48 REF.Article

LES RISQUES DES POTENTIALISATIONS DE PSYCHOTROPES PAR LE DIPROPYLACETAMIDE (16 OBSERVATIONS)PATY J; BOURGEOIS M.1978; ENCEPHALE; FRA; DA. 1978; VOL. 4; NO 3; PP. 251-265; ABS. ENG; BIBL. 17 REF.Article

EFFECT OF SODIUM VALPROATE ON HYPOTHALAMIC NEURONS IN VIVO AND IN VITROBALDINO F JR; GELLER HM.1981; BRAIN RES.; ISSN 0006-8993; NLD; DA. 1981; VOL. 219; NO 1; PP. 231-237; BIBL. 20 REF.Article

TREMBLEMENT AU COURS D'UN TRAITEMENT PAR LE VALPROATE DE SODIUMDUGAS M; BRUNOD R; MASSON M et al.1981; NOUV. PRESSE MED.; ISSN 0301-1518; FRA; DA. 1981; VOL. 10; NO 34; PP. 2828; BIBL. 4 REF.Article

A CASE OF FATAL TOXIC HEPATITIS: RECOMMENDATIONS FOR THE ADMINISTRATION OF SODIUM VALPROATEGASTAUT H; NOEL P.1981; EPILEPSIA; ISSN 0013-9580; NLD; DA. 1981; VOL. 22; NO 6; PP. 711-713; ABS. SPA/FRE/GER; BIBL. 8 REF.Article

DAS VALPROINAT = VALPROATEKARBOWSKI K.1980; PRAXIS; CHE; DA. 1980; VOL. 69; NO 23; PP. 809-813; ABS. ENG/FRE; BIBL. 33 REF.Article

NONSEDATIVE REGIMENS IN THE TREATMENT OF EPILEPSYPORTER RJ; THEODORE WH.1983; ARCHIVES OF INTERNAL MEDICINE (1960); ISSN 0003-9926; USA; DA. 1983; VOL. 143; NO 5; PP. 945-947; BIBL. 29 REF.Article

HYPERAMMONEMIA WITH VALPROIC ACID THERAPYCOULTER DL; ALLEN RJ.1981; J. PEDIATR.; ISSN 0022-3476; USA; DA. 1981; VOL. 99; NO 2; PP. 317-319; BIBL. 10 REF.Article

TRANSMISSION OF VALPROIC ACID (DEPAKENE) ACROSS THE PLACENTA: HALF-LIFE OF THE DRUG IN MOTHER AND BABYDICKINSON RG; HARLAND RC; LYNN RK et al.1979; J. PEDIATR.; USA; DA. 1979; VOL. 94; NO 5; PP. 832-835; BIBL. 10 REF.Article

PHARMACOKINETIC STUDY OF VALPROIC ACID IN A NEONATEIRVINE MEEK JM; HALL KW; OTTEN NH et al.1982; PEDIATRIC PHARMACOLOGY (NEW YORK, N.Y.); ISSN 0270-322X; USA; DA. 1982; VOL. 2; NO 4; PP. 317-321; BIBL. 2 P.Article

THROMBOZYTENWERTE BEI ERWACHSENEN UNTER BEHANDLUNG MIT DPA (ERGENYL). = NOMBRE DE THROMBOCYTES CHEZ LES ADULTES SOUS TRAITEMENT DE DPA (ERGENYL)KRAUSE KH.1977; MED. WELT; DTSCH.; DA. 1977; NO 24; PP. 1098-1099; BIBL. 2 REF.Article

Distribution of valproic acid and its metabolites in various brain areas of dogs and rats after acute and prolonged treatmentLÖSCHER, W; NAU, H.The Journal of pharmacology and experimental therapeutics. 1983, Vol 226, Num 3, pp 845-854, issn 0022-3565Article

VALPROIC ACID AND FETAL ABNORMALITYBAILEY CJ; POOL RW; POSKITT EM et al.1983; BRITISH MEDICAL JOURNAL; ISSN 0007-1447; GBR; DA. 1983; VOL. 286; NO 6360; PP. 190; BIBL. 5 REF.Article